The STEP 1 trial, a 68-week randomized controlled trial published in the New England Journal of Medicine in 2021, evaluated semaglutide 2.4 mg (the maximum approved dose, though some references cite 2.5 mg as the target maintenance dose) versus placebo in adults with obesity or overweight status but without diabetes. The trial demonstrated that semaglutide-treated patients achieved a mean weight loss of approximately 14% from baseline compared to 2.4% in the placebo group, representing a difference of approximately 10 percentage points in weight reduction. The drug was titrated over 16 weeks using a standard escalation protocol beginning at 0.25 mg weekly, with the primary endpoint being change in body weight from baseline to week 68.
Common adverse events in the semaglutide arm included gastrointestinal symptoms, primarily nausea, vomiting, and diarrhea. The incidence of nausea ranged from mild to moderate in most patients and was generally transient, diminishing over time as patients continued treatment. Discontinuation rates due to adverse events were higher in the semaglutide group compared to placebo, though the majority of patients who experienced gastrointestinal side effects remained on treatment. No serious pancreatitis or significant safety signals emerged during the trial period.
For prescribers, these findings establish semaglutide 2.4 mg as an effective pharmacologic intervention for weight management in non-diabetic patients with obesity or overweight, with a substantial and clinically meaningful weight reduction that exceeds what is typically achieved with lifestyle modification alone. The predictable gastrointestinal tolerability profile allows for patient counseling and expectation management. The trial provides the evidence base supporting the use of this agent in primary care and specialty settings for weight management in appropriate patient populations.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is semaglutide and how does it work?
Semaglutide is a GLP-1 receptor agonist medication that works by mimicking a natural hormone in your body that controls blood sugar and appetite. It helps you feel fuller longer and reduces hunger signals, which leads to eating less and losing weight.
Is semaglutide only for people with diabetes?
No, semaglutide can be prescribed to people without diabetes who have obesity or are overweight and need help with weight management. The STEP 1 clinical trial specifically studied adults without diabetes who used semaglutide successfully.
What was shown in the STEP 1 trial?
The STEP 1 trial was a major study published in the New England Journal of Medicine in 2021 that followed adults without diabetes for 68 weeks. It demonstrated that semaglutide was effective for weight loss in people with obesity and overweight conditions.
What is the typical starting dose of semaglutide?
Semaglutide treatment typically begins at lower doses and is gradually increased over time to help your body adjust and minimize side effects. Your doctor will determine the right dosing schedule based on your individual needs and tolerance.
What are the common side effects of semaglutide?
The most common side effects include nausea, vomiting, diarrhea, and constipation, especially when first starting the medication or increasing doses. These side effects are often temporary and tend to improve as your body adjusts to the medication.
How much weight can I expect to lose with semaglutide?
Weight loss results vary from person to person, but clinical trials have shown significant weight reduction in many patients. Your actual results will depend on your starting weight, lifestyle changes, diet, and exercise habits.
How long does it take to see results from semaglutide?
Most people begin to notice appetite reduction and early weight loss within the first few weeks of treatment. More significant weight loss typically occurs over several months of continued use combined with healthy eating and exercise.
Is semaglutide a permanent solution for weight loss?
Semaglutide is a tool to help with weight management, but it works best when combined with lifestyle changes like healthy eating and regular physical activity. Some people may need to continue the medication long-term to maintain their weight loss results.
What happens if I stop taking semaglutide?
If you stop taking semaglutide, your appetite typically returns to normal and you may regain some or all of the weight you lost. It is important to discuss any changes to your treatment plan with your doctor before stopping the medication.
Are there people who should not take semaglutide?
People with a personal or family history of certain thyroid cancers or multiple endocrine neoplasia should not take semaglutide. You should tell your doctor about all your medical conditions and medications so they can determine if semaglutide is safe for you.
